Loading ...

Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

MHC Db Ig dimer/anti CD-28-conjugated poly(lactic-co-glycolic acid) nanoparticles

Based on

1 Articles
2015 Most recent source

Composition

1

MHC Db Ig dimer/anti CD-28-conjugated poly(lactic-co-glycolic acid) nanoparticles

MHC Db Ig dimer/anti CD-28-conjugated PLGA nanoparticles MHC Db Ig dimer/anti CD-28-conjugated PLGA NP
Type Nano Material
Formula
Role raw materials
2

tetramethylrhodamine isothiocyanate fragment

tetramethylrhodamine TRITC fragment rhodamine IRIS-3 TAMRA TMR
Type Single Compound
Formula C24H22N2O3
Role loaded material

Properties

Applications

Area Application Nanomaterial Variant Source
medicine/veterinary

More information available to subscribers only.

Or, view sample content

Characterization

Biological effects

Biological system Test details Nanomaterial Variant Source
human umbilical vein endothelial cells (HUVECs)

More information/entries available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Chemical synthesis
Source:
  1. siR1qtKchM
Product

MHC Db Ig dimer/anti CD-28-conjugated poly(lactic-co-glycolic acid) nanoparticles

Size: not specified

Medium/Support: none

Method 2

Type: Chemical synthesis
Source:
  1. CE3fCLTw4C
Product

MHC Db Ig dimer/anti CD-28-conjugated poly(lactic-co-glycolic acid) nanoparticles

Size: not specified

Medium/Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial